!

COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Nagireddy Putluri Lab

Projects

Master
Heading

Funded Projects

Content

Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers (NIH/NCI RO1CA216426).
Role: Primary Investigator Dates of Funding: April 1, 2018 - March 30, 2023
Annual Direct Cost and Direct Cost for Entire Funding Period: $325,736 Annual Direct Cost and $1,590,943 for Entire Funding Period (total $1,984,358 cost over 5 years)

Racial Disparity in Bladder Cancer and Identification of Altered Metabolism in African American Compare To European Bladder Cancer (NIH/NCI R01CA220297)
Role: Primary Investigator
Dates of Funding: June 1, 2017 - May 31, 2022
Annual Direct Cost and Direct Cost for Entire Funding Period: $233,911 Annual Direct Cost and $1,169545 for Entire Funding Period. (total $1,819,903 cost over 5 years)

Elucidating the Role of Xenobiotic Metabolism in Bladder Cancer Progression (American Cancer Society).
Grant Number: 127430-RSG-15-105-01-CNE
Role: Primary Investigator
Dates of Funding: July 1, 2015 - June 30, 2019
Annual Direct Cost and Direct Cost for Entire Funding Period: $198,000 Annual Direct Cost and $792,000 for Entire Funding Period

Heading

Other Projects

Content

Integrated Circulating Biomarkers and Imaging Modalities for Early Detection of Pancreatic Ductal Adenocarcinoma
Name of funding agency: NIH/NCI (UO-1)
Role: Co-Investigator (PI for BCM)
Grant Number: U01CA214263
Dates of Funding: June 1, 2018 - Nov. 30, 2022
Funding: $100,000 /yr direct cost
Note: This project is collaboration with Dr. Subrata Sen (PI), MD Anderson.

To Establish a Cancer Metabolomics Core Facility at Baylor College of Medicine
Name of Funding Agency: CPRIT
Grant Number: RP170005
Role: Core Director/Co-Investigator
Dates of Funding: Dec. 1, 2016 - Nov. 30, 2021
Annual Direct Cost and Direct Cost for Entire Funding Period: $250,000 Annual Direct Cost and $1,25,000 for Entire Funding Period

Metabolomics Shared Resource
Name of Funding Agency: NIH/NCI
Grant Number (if applicable): P30 CA125123-09
Role: Core Director/Co-Investigator
Dates of Funding: July 1, 2015 - June 30, 2020
Annual Direct Cost and Direct Cost for Entire Funding Period: $50,000 Annual Direct Cost and $250,000 for Entire Funding Period

Delineating Racially Distinct Metabolic Pathways in Triple Negative Breast Cancer
Name of Funding Agency: NIH/NCI
Grant Number: UO1CA179674-01A1
Role: Core Director/Co-Investigator
Dates of funding: July 1, 2014 - June 30, 2019
Annual Direct Cost and Direct Cost for Entire Funding Period: $250,000 Annual Direct Cost and $1,250,000 for Entire Funding Period

Technical Title of Project: Preclinical Analyses of NAD Kinase as a Redox Vulnerability for the Treatment of Pancreatic Cancer
Name of Funding Agency: NIH/NCI
Grant Number: R01CA211176
Role: Co-Investigator
Dates of Funding: April 4, 2001 - March 31, 2021
Annual Direct Cost and Direct Cost for Entire Funding Period: $250,000 Annual Direct Cost and $1,250,000 for Entire Funding Period

Technical Title of Project: Neurobehavioral and Biochemical Outcome Measures in Rett Syndrome Rodent Models
Name of Funding Agency: NIH/NCI
Grant Number: NIH/NICHD- R01 HD083181
Role: Co-Investigator
Dates of Funding: July 1, 2017 - June 30, 2021
Annual Direct Cost and Direct Cost for Entire Funding Period: $250,000 Annual Direct Cost and $1,250,000 for Entire Funding Period

Clinico-pathological Correlation & Molecular Signature Identification & Risk Stratification of Prostate Cancer in African American U.S. Veterans, with & without Exposure to Battlefield Chemicals
Name of Funding Agency: Prostate Cancer Foundation
Role: Co-Investigator
Dates of Funding: Oct. 1, 2017 - Aug. 31, 2019
Annual Direct Cost and Direct Cost for Entire Funding Period: $114,000 Annual Direct Cost and $228,000 for Entire Funding Period

This grant funds development of non-invasive metabolic markers in serum/plasma and urine for cancer detection and prognosis.
Name of Funding Agency: Agilent Technology
Grant Number: Agilent Mass Spectrometry -COE
Role: Co-Investigator
Dates of Funding: Aug. 1, 2017 - July 31, 2022
Annual Direct Cost and Direct Cost for Entire Funding Period: $250,000 Annual Direct Cost and $1,250,000 for Entire Funding Period

Mitochondrial DNA Copy Number and Fat Metabolism in Triple Negative Breast Cancer
Name of Funding Agency: NIH/NCI
Specify Grant, Contract or Other: Grant
Grant Number: R03CA212816
Role: Co-Investigator
Dates of Funding: August 2017 - August 2019
Annual Direct Cost and Direct Cost for Entire Funding Period: $50,000 Annual Direct Cost and $100,000 for Entire Funding Period